ArticleThe Journal of international medical research2026
Identification of key genes and mechanistic exploration of metabolic reprogramming in osteoporosis.
Article in The Journal of international medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveTo identify metabolism-related genes associated with osteoporosis and evaluate their diagnostic potential through integrative transcriptomic analysis and clinical validation.MethodsSingle-cell RNA sequencing data from GSE169396 were analyzed using the Seurat package to investigate interactions between monocytes and other cell types. Metabolic pathway alterations in osteoporosis were evaluated using single-sample gene set enrichment analysis. Differentially expressed genes were intersected with metabolism-related genes to identify differentially expressed metabolism-related genes. Key metabolic genes were screened using the least absolute shrinkage and selection operator, support vector machine-recursive feature elimination, and Boruta algorithms, and a logistic regression model was established to assess their diagnostic value. External quantitative reverse transcription polymerase chain reaction validation was performed using peripheral blood mononuclear cells from patients with osteoporosis and healthy controls. Receiver operating characteristic curve analysis was used to evaluate the predictive performance of individual genes and the combined model.ResultsSingle-cell interaction analysis revealed close communication between monocyte subsets and hematopoietic stem cells, endothelial cells, cDC2, cDC1, T cells, and plasmacytoid dendritic cells. Significant alterations were observed in valine, leucine, and isoleucine biosynthesis; purine metabolism; fatty acid biosynthesis and elongation; ascorbate and aldarate metabolism; and steroid biosynthesis. Intersection analysis identified 11 differentially expressed metabolism-related genes from 232 metabolism-related genes and 395 differentially expressed genes. Integrative machine learning identified seven key metabolic genes: ADSL, BCAT1, BCAT2, PDE8A, NPR2, SOAT2, and XDH. External validation confirmed significant differential expression of these genes between patients with osteoporosis and healthy controls. The logistic regression model showed excellent diagnostic performance, with an area under the curve of 0.935, whereas all individual genes achieved area under the curve values above 0.7. Gene set enrichment analysis indicated that these genes were enriched in pathways related to G protein-coupled receptor activity.ConclusionsWe identified seven key metabolic genes associated with osteoporosis, namely, ADSL, BCAT1, BCAT2, PDE8A, NPR2, SOAT2, and XDH, and demonstrated their promising diagnostic potential. These findings provide new insights into the metabolic mechanisms underlying osteoporosis and may support the development of future diagnostic biomarkers and therapeutic targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.